Law & Regulation

Published by
CorpWatch
|
By |
The algorithms that make social media addictive have become powerful mechanisms for drug dealers to peddle prescription-only medicines and banned substances. One of the more popular tools for pushers is Instagram where dealers market drugs like Adderall, Oxycontin and Xanax, used to treat attention deficit hyperactivity disorder, pain and anxiety respectively. Read More
Published by
CorpWatch
|
By |
New York city is the latest U.S. city to bring a lawsuit against Purdue Pharmaceutical and other companies involved in manufacturing and distributing prescription painkillers, known as opioids. Some 250 such lawsuits have been filed alleging that deceptive industry marketing practices have caused opioid overdose deaths to skyrocket. Read More
Published by
CorpWatch Blog
|
By |
Takata, the Japanese auto parts maker, will pay a $1 billion fine to the U.S. government after pleading guilty to hiding information about the likelihood that the company’s car air bags could accidentally explode. Takata air bags have been linked to at least 17 deaths around the world. Read More
Published by
CorpWatch Blog
|
By |
Police departments across the U.S. pay AT&T, the telecommunications giant, over one hundred thousand dollars a year for special access to telephone records of clients without first obtaining a warrant. The program is called 'Hemisphere' and the company required buyers to keep its existence secret. Read More
Published by
CorpWatch Blog
|
By |
Representatives of some 280 indigenous nations have joined a protest on the Standing Rock Sioux reservation in North Dakota to oppose the construction of an oil pipeline by Energy Transfer Partners. If completed, the Dakota Access Pipeline is expected to help move 570,000 barrels of crude daily to Illinois. Read More
Published by
Special to CorpWatch
|
By |
Six executives of Swiss pharmaceutical giant Novartis have been indicted in a South Korean bribery scandal. The indictments follow similar charges in China, Turkey and the U.S. and allegations of falsifying drug trial data in Japan. Korean prosecutors have recommended that Novartis sales be suspended for six months. Read More
* indicates required